Researchers at the Stanford University School of Medicine have challenged decades of accepted wisdom about bone marrow transplantation with a new study showing that mice receiving purified blood stem cells are less prone to complications than mice receiving stem cells plus purified T cells.The study, led by Judith Shizuru, MD, PhD, associate professor of medicine, will be published online Aug. 2 ...